H.R.5020: Synthetic Drug Awareness Act of 2016

About This Bill

Bill Summary

Synthetic Drug Awareness Act of 2016 This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 2 statements associated with H.R.5020.

Bill Actions

Date Description
April 22, 2016
Referred to the Subcommittee on Health.
April 21, 2016
Referred to the House Committee on Energy and Commerce.
April 21, 2016

Introduced in the House by Hakeem Jeffries (D-N.Y.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page